| Varieties: | Growth Promoting Medicine |
|---|---|
| Component: | Animal |
| Type: | The First Class |
| Pharmacodynamic Influential Factors: | Animal Species |
| Storage Method: | Cool Dry Area |
| Product Name: | Ponazuril |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
|
|
Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by
Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small
animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
1. Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
2. Ponazuril have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
|
Items |
Standards |
Results |
|
Physical Analysis |
||
|
Description |
White Powder | Complies |
|
Assay |
99% | 99.6% |
|
Mesh Size |
100 % pass 80 mesh | Complies |
|
Ash |
≤ 5.0% | 2.85% |
|
Loss on Drying |
≤ 5.0% | 2.65% |
|
Chemical Analysis |
||
|
Heavy Metal |
≤ 10.0 mg/kg |
Complies |
|
Pb |
≤ 2.0 mg/kg |
Complies |
|
As |
≤ 1.0 mg/kg | Complies |
|
Hg |
≤ 0.1mg/kg | Complies |
|
Microbiological Analysis |
||
|
Residue of Pesticide |
Negative | Negative |
|
Total Plate Count |
≤ 1000cfu/g | Complies |
|
Yeast&Mold |
≤ 100cfu/g | Complies |
|
E.coil |
Negative |
Negative |
|
Salmonella |
Negative |
Negative |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}